Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients.

Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients.

The efficacy and safety of the boceprevir (BOC)-containing triple therapy in Taiwanese treatment-experienced patients remains elusive. After 4 weeks of peginterferon/ribavirin lead-in therapy, patients with cirrhosis or previous null-response received triple therapy for 44 weeks; whereas others rece...

Full description

Bibliographic Details
Main Authors: Chi-Chieh Yang, Wei-Lun Tsai, Wei-Wen Su, Chung-Feng Huang, Pin-Nan Cheng, Ching-Chu Lo, Kuo-Chih Tseng, Lein-Ray Mo, Chun-Hsiang Wang, Shih-Jer Hsu, Hsueh-Chou Lai, Chien-Wei Su, Chun-Jen Liu, Cheng-Yuan Peng, Ming-Lung Yu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4569190?pdf=render

Internet

http://europepmc.org/articles/PMC4569190?pdf=render

Similar Items